HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ethyl tyrosine ester

RN given refers to L-isomer

Also Known As:

ethyl tyrosine; ethyl tyrosine ester hydrochloride, (D)-isomer; ethyl tyrosine ester hydrochloride, (L)-isomer; ethyl tyrosine ester, (D)-isomer

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Tyrosine: 10509
        ethyl tyrosine ester: 6

Experts

1.	Małkowski, Bogdan: 2 articles (01/2022 - 01/2019)
2.	Blok, Maciej: 1 article (01/2022)
3.	Harat, Maciej: 1 article (01/2022)
4.	Makarewicz, Karolina: 1 article (01/2022)
5.	Miechowicz, Izabela: 1 article (01/2022)
6.	Wiatrowska, Izabela: 1 article (01/2022)
7.	Backhaus, Philipp: 1 article (01/2020)
8.	Barca, Cristina: 1 article (01/2020)
9.	Dollé, Frédéric: 1 article (01/2020)
10.	Döring, Christian: 1 article (01/2020)

Related Diseases

1.	Multiple Myeloma 01/01/2019 - "The aim of this study was to analyse the diagnostic accuracy of "18F-fluoro-ethyl-tyrosine (18F-FET) PET/CT tracer in multiple myeloma. "
2.	Glioma (Gliomas) 05/01/2015 - "Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma." 01/01/2020 - "To characterize the glioma TME, a mixed collective of 9 glioma patients underwent [18F]DPA-714-PET-MRI in addition to [18F]fluoro-ethyl-tyrosine (FET)-PET-MRI. "
3.	Glioblastoma (Glioblastoma Multiforme) 01/01/2022 - "Dual timepoint fluoro-ethyl-tyrosine (FET)-PET acquisition (10 and 60 minutes after FET injection) improves the definition of glioblastoma (GBM) location and shape. " 01/01/2023 - "We present the case of a heavily pretreated 42-year-old man with BRAF V600E mutant and SOX2 amplification glioblastoma having a radiologic and metabolic [analyzed by a brain 18F-fluoro-ethyl-tyrosine([18F]FET) PET/MRI] complete response to the combination therapy with dabrafenib plus trametinib and silybin, a potent STAT3 inhibitor. "
4.	Neoplasms (Cancer) 01/01/2019 - "Secondary endpoints are progression-free survival (PFS), and tumor response (based upon assessment with C-methionine/fluoro-ethyl-tyrosine positron emission tomography [MET/FET PET] or magnetic resonance imaging [MRI] and detection of serologic immune markers). "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	Methionine (L-Methionine)
3.	Silybin (Lagosa)
4.	dabrafenib
5.	trametinib
6.	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamide

Related Therapies and Procedures

1.	Therapeutics
2.	Radiotherapy